Phase 3 Merkel Cell Carcinoma Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 2Phase 3

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Advanced Or Metastatic Merkel Cell Carcinoma

TuHURA Biosciences, Inc.118 enrolled8 locationsNCT06947928

Recruiting

Phase 3

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Triple-Negative Breast CancerCervical CancerUrothelial Carcinoma+12 more

UNICANCER646 enrolled40 locationsNCT05078047